Dieter Bruno, MD
Peninsula Urology Center, Inc.
Dr. Bruno joined the practice in September 2007. Dr. Bruno was Dr. Threatt’s mentor and professor at Duke University in the Department of Urology. Dr. Bruno received his medical school and urologic training at Duke University Medical Center. He has held faculty positions at Duke University Medical Center as well as East Carolina University School of Medicine. While on the faculty at Duke University he won an award for best teacher. His clinical focus has been on male and female incontinence, advanced endoscopic stone manipulation, and advanced laparoscopic/robotic techniques.
He was responsible for beginning the prostate cancer brachytherapy program at East Carolina University School of Medicine in 2003 and the urologic robotic program at East Carolina University School of Medicine in 2002. He is credited with performing the first daVinci urologic robotic surgical procedure (nephrectomy) as well as the second daVinci robotic prostatectomy in the state of North Carolina. Currently Dr Bruno is an educator regarding advanced robotic surgical techniques as well as brachytherapy. He is a certified proctor for Bard Urology (brachytherapy division), as well as Intuitive Surgical Corporation (daVinci robot). He has performed hundreds of robotic prostatectomies and has proctored numerous urologists in robotic techniques in North Carolina as well as California and currently teaches courses for Intuitive Surgical. His repertoire of robotic surgical techniques includes nephrectomy, prostatectomy, pyeloplasty, partial cystectomy, sacrocolpopexy and hysterectomy.
puc-news.jpgHe is currently the Chief of Surgery and medical director of the Robotic and Minimally Invasive Surgical program at CHW Sequoia Hospital.
He is a board certified urologist and a fellow of the American College of Surgeons.
Dr. Bruno has recently appeared on 6 TV segments. Click here to view the health and wellness: access, health and wellness:mens issues, health and wellness: womens issues, womens health interview, the prostate cancer segment or the womens health segment.